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Synovial joints are assumed to originate
from a set of early-specified progenitors.
Using a knockin Gdf5-CreERT2 mouse,
Shwartz et al. show that joints develop
through a continuous influx of cells into
the interzone. The complex
spatiotemporal dynamics of Gdf5
expression may reveal a mechanism of
lineage divergence.
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Synovial joints comprise several tissue types,
including articular cartilage, the capsule, and liga-
ments. All of these compartments are commonly
assumed to originate from an early set of Gdf5-ex-
pressing progenitors populating the interzone
domain. Here, we provide evidence that joints
develop through a continuous influx of cells into the
interzone, where they contribute differentially to
forming joint tissues. Using a knockin Gdf5-CreERT2
mouse, we show that early labeling of Gdf5-positive
interzone cells failed to mark the entire organ.
Conversely, multiple Cre activation steps indicated
a contribution of these cells to various joint com-
partments later in development. Spatiotemporal dif-
ferences between Gdf5 and tdTomato reporter
expression support the notion of a continuous
recruitment process. Finally, differential contribution
of Gdf5-positive cells to various tissues suggests
that the spatiotemporal dynamics ofGdf5 expression
may instruct lineage divergence. This work supports
the influx model of joint development, which may
apply to other organogenic processes.INTRODUCTION
According to the prevailing model, organogenesis is initiated
with the specification of a subset of cells as progenitors that
are then organized to form a primordium. As development pro-
ceeds, the primordium undergoes extensive growth, differentia-
tion, and morphogenesis until the organ obtains its final form
(Biehs et al., 2013; Garrison et al., 2009; Go¨ttgens, 2013; Gu
et al., 2002; Little, 2011; Stanger et al., 2007; Wilkinson andGo¨tt-
gens, 2013). Synovial joints are structures that separate adjacent
skeletal elements and thus allow locomotion. The mature joint is
composed of articular cartilage, synovial fluid, ligaments, and a
fibrous capsule, which together function to transmit biomechan-
ical loads during skeletal motion (Decker et al., 2014).
The first histological indication for joint formation is the
appearance of a higher cell density domain called the interzone
at the site of the future joint. The interzone consists of three
layers, the middle of which is termed the intermediate zoneCel
This is an open access article under the CC BY-N(Mitrovic, 1977). Molecularly, interzone cells lose the expression
of chondrocyte-specific genes such as collagen type II. Instead,
they express a new set of genes that includes growth and differ-
entiation factor 5 (Gdf5), Wnt4, and Wnt9a (Guo et al., 2004;
Hartmann and Tabin, 2001; Spa¨ter et al., 2006; Storm et al.,
1994).
Over the years, it has been suggested that interzone cells
serve as joint progenitors. Removal of the interzone was shown
to lead to joint loss and bone fusion (Holder, 1977). Light and
electron microscopy studies have suggested that interzone
cells from the two outside layers contribute secondarily to
the adjacent epiphyses, whereas intermediate zone cells
form the external layers of the joint (Ito and Kida, 2000). Finally,
lineage studies utilizing Gdf5-Cre mice showed that cells of
all mature joint components originate from Gdf5-expressing
lineages, further promoting the view that interzone cells are
joint progenitors (Koyama et al., 2007, 2008; Rountree et al.,
2004).
Theseworks support amodel in which, during the initial stages
of skeletogenesis, a subset of mesenchymal cells is specified as
interzone cells to serve as joint progenitors. However, evidence
accumulated in recent years indicates that, during development,
cells from the vicinity are integrated into the forming joint (Hyde
et al., 2008; Koyama et al., 2007; Pacifici et al., 2006; Ray
et al., 2015). These findings suggest a more elaborate mode of
development, reopening the question of whether joint develop-
ment follows the widely accepted scheme of organogenesis. In
this study, we use a new Gdf5-CreERT2 knockin mouse line to
propose a revised model for joint development. We show that
joint development occurs through a continuous influx of new
cells that are integrated into the interzone, where they contribute
to the forming joint, hence the term influxmodel. Finally, we show
that this mechanism facilitates lineage divergence and, thereby,
joint development.RESULTS
Establishment of the Gdf5-CreER Knockin Mouse as a
Model System
The current consensus that Gdf5-positive interzone cells are
joint progenitors has been based on lineage tracing experiments
using a Gdf5-Cre transgenic mouse. This line was produced by
integrating the Cre recombinase sequence into a 140-kb bacte-
rial artificial chromosome (BAC) containing the Gdf5 locus
(Rountree et al., 2004). This transgene might not contain alll Reports 15, 2577–2587, June 21, 2016 ª 2016 The Authors. 2577
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
of the potential regulatory elements that control endogenous
Gdf5 expression and might also be influenced by the genomic
integration site. Therefore, to directly test that view, we sought
to generate a Gdf5-CreERmouse that would allow us to tempo-
rally labelGdf5-expressing cells. Taking a knockin approach, we
inserted a cassette encoding for CreER into the translation start
site of the Gdf5 gene using homologous recombination (Fig-
ure S1Aa). To demonstrate both the accuracy and the efficiency
of the new Gdf5-CreER line, we crossed this mouse with a
Rosa26-tdTomato reporter line and induced recombination by
a single tamoxifen dose administered on embryonic day (E)
13.5. Whole-mount preparations of E18.5 embryos showed
that joints in the vertebrae, forelimb, and hindlimb were marked
(Figures S1Ab–S1Ad’’), suggesting that Cre recombinase
activity was indeed restricted to joints. Importantly, no reporter
activity was evident without tamoxifen administration (Figures
S1Ba–S1Bc).
Next, we crossed mice heterozygous for Gdf5-CreER and
analyzed the homozygous offspring. As expected, the pheno-
type recapitulated that of brachypodism (bp) mice (Harada
et al., 2007; Mikic, 2004; Storm et al., 1994); namely, malforma-
tion in the autopods and fibula, failure of cruciate ligament devel-
opment, and expansion of the Gdf5 expression domain in the
autopod (Figures S1Ca–S1Ce’). Together, these results indicate
that theGdf5-CreER line is a suitable system for lineage analysis
of Gdf5-positive interzone cells.
Joint-Forming Cells Are Not Specified in a Single Early
Event
According to the interzone progenitor model, once the interzone
has formed, the cells inside it are specified as joint progenitors,
as indicated by Gdf5 expression. This hypothesis predicts that
administration of tamoxifen at that stage would ‘‘capture’’
most of the population of joint progenitors, resulting in cell label-
ing throughout the joint. To directly examine this hypothesis, we
performed a series of pulse-chase experiments by crossing
Gdf5-CreER mice with the Rosa26-tdTomato reporter. As seen
in Figure 1A, on E11.5, Gdf5 expression was clearly observed
in the presumptive elbow, knee, and autopod joints. Assuming
a 24-hr delay inmaximumCre activity, a single dose of tamoxifen
was administered on E10.5 to labelGdf5-positive interzone cells.
Interestingly, analysis of sections through the knee, elbow, and
metacarpophalangeal joints on E18.5 showed only restricted
labeling, mostly of epiphyseal cells (Figure 1B). This surprising
result suggests that the Gdf5-positive cells that populate the
interzone at the time of its formation are not the main source of
joint progenitors.
An alternative hypothesis that could reconcile our observa-
tions with those obtained previously using the Gdf5-Cre line is
that there is a constant inflow of new cells into the forming joint.
The ‘‘influx’’ model predicts that a single administration of
tamoxifen will mark only a partial population of joint cells and
that only several administrations at different developmental
stages will induce extensive labeling. To test this hypothesis,
we administered three doses of tamoxifen on E11.5, E13.5,
and E15.5. Examination of sections through several E18.5 joints
showed that tdTomato-positive cells occupied most of the joint
area (Figure 1C), thus reinforcing the influx hypothesis.2578 Cell Reports 15, 2577–2587, June 21, 2016The interzone progenitor model implies a requirement for
continuous proliferation of the progeny of early-specified
Gdf5-positive progenitors throughout development to sustain
rapid joint growth. To further distinguish between the two hy-
potheses, we examined the proliferative potential of these
cells. We analyzed, by bromodeoxyuridine (BrdU) assay, the
descendants of Gdf5-positive cells labeled by a single tamox-
ifen administration on E11.5. Sections through the elbow and
knee joints showed that approximately 20% of the descen-
dants, marked by tdTomato, were proliferating on E13.5.
Moreover, the level of proliferation dramatically decreased
through E15.5 and E18.5 (Figures 1D and 1E). Taken together,
these results imply a continuous influx of cells into the forming
joint.
Joint Development Involves a Continuous Influx of New
Gdf5-Expressing Cells
Next, to directly demonstrate the recruitment process, we moni-
tored the spatial distribution ofGdf5 and tdTomato expression in
the interzone during development. The probe for the tdTomato
gene was expected to mark cells that have already been speci-
fied asGdf5-positive at the time of tamoxifen administration and
their descendants, whereas the probe for Gdf5would mark cells
that expressed Gdf5 at the time of harvesting. Thus, expression
of both markers would indicate cells that were recruited early
and maintained Gdf5 expression, whereas newly recruited,
non-pulsed cells would express only Gdf5. First, to verify the
sensitivity of in situ hybridization (ISH) for tdTomato, we
compared the results of that assay (red) with immunofluorescent
staining for tdTomato protein (green) (Figure 2A). The co-locali-
zation of labeled cells showed that ISH for tdTomato is a reliable
tool in cell lineage studies.
According to our model, immediately after Cre activation,
interzone cells should express both Gdf5 and tdTomato. To
examine this assumption, we performed double ISH for both
genes on sections from Gdf5-CreER, Rosa26-tdTomato em-
bryos following administration of a single dose of tamoxifen
at different time points during joint development (E11.5–
E13.5). Embryos were harvested 28 hr after tamoxifen adminis-
tration because we had expected a delayed activation of the
Rosa26 reporter. In agreement with our hypothesis, sections
through the knee showed a high overlap between Gdf5- and
tdTomato-positive cells pulsed at all the time points (Figures
2B and S2).
To assess the efficiency of Gdf5-CreER recombination quan-
titatively, we measured the level of co-localization of Gdf5- and
tdTomato-expressing cells. The results showed that 60%–67%
of the Gdf5 expression domain was also positive for tdTomato
(Figure 2C). Surprisingly, 28 hr after tamoxifen administration,
we already observed a population of tdTomato-positive, Gdf5-
negative cells (Figure 2B, arrows). Assessment of the proportion
of that population relative to the entire tdTomato expression
domain showed that, at all examined stages, approximately
30% of tdTomato-positive cells had already lost Gdf5 expres-
sion. This observation indicates a very dynamic cellular behavior
and suggests that the actual recombination efficiency is higher
than calculated (Figures 2C and 2D). Moreover, the coexpres-
sion of Gdf5 and tdTomato by most cells after that interval
Figure 1. Limited Proliferation of Gdf5+ Lineage Cells Contradicts the Interzone Progenitor Hypothesis
(A) Sections through the knee, elbow, and autopod of E11.5 embryos show Gdf5 expression in various joints.
(B) Pulse-chase lineage tracing experiment with a single dose of tamoxifen administered on E10.5 to mark approximately the same cell populations shown in (A).
Sections through E18.5Gdf5-CreER, Rosa26-tdTomato embryo knee, elbow, and metacarpophalangeal joints show that tdTomato-positive cells do not occupy
most of the joint area.
(C) Left: illustration of the predicted outcome of multiple tamoxifen (Tm) administrations according to the influx model. Right: sections through E18.5 forelimb and
hindlimb following repeated pulsing on E11.5, E13.5, and E15.5 show numerous tdTomato-positive cells at the knee (top left), elbow (top right), meta-
carpophalangeal (bottom left), and humeroscapular (bottom right) joints, consistent with the model.
(D) Pulse-chase experiment with a single dose of tamoxifen administered on E11.5. Shown is immunofluorescent staining for BrdU (green) and tdTomato (red) on
sections through elbow and knee joints on E13.5, E15.5, and E18.5 (arrows indicate double-labeled cells).
(E) Quantification of the percentage of proliferating descendants of Gdf5-expressing cells on E13.5, E15.5, and E18.5.
Scale bars represent 100 mm.demonstrated our ability to effectively detect the expression of
both markers as well as the high level of Cre activity following
a single tamoxifen administration.
Another prediction of our model is that longer pulse-chase
intervals would reduce the overlap between the Gdf5 and
tdTomato expression domains as a result of Gdf5 expression
by cells recruited after pulsing. Indeed, examination of E13.5–
E15.5 knee joints of embryos pulsed on E11.5 showed that, in
addition to cells that co-expressed both markers, a high number
of cells expressed only Gdf5 but not tdTomato (Figure 2E, ar-
rows). As in the previous experiment (Figure 2B), a third popula-
tion of cells that solely expressed tdTomato was also identified,presumably having lost Gdf5 expression. These results reveal a
highly dynamic behavior of joint-forming cells; new cells turn
Gdf5 expression on, whereas others turn it off.
Because, in that experiment, tamoxifen was administered only
on E11.5, the observed dynamic behavior could be unique to that
developmental stage. To address that issue, we repeated the
pulse-chase experiments, administering single doses of tamox-
ifen at different stages (E10.5–E13.5), and examined tdTomato
and Gdf5 expression in the knee joint on E15.5. In all experi-
ments, the three abovementioned populations were detected
(Figure 2F), indicating a continuous influx of Gdf5-positive cells
into the joint.Cell Reports 15, 2577–2587, June 21, 2016 2579
Figure 2. Joint Development Involves Continuous Steps of Recruitment and Specification of New Cells
(A) Immunofluorescent staining (green) and gene expression (red) of the tdTomato reporter demonstrate reliable detection of the reporter by ISH.
(B) Double ISH for Gdf5 (green) and tdTomato (red) genes on E12.5–E14.5, following administration of a single tamoxifen dose on E11.5–E13.5, respectively,
shows that almost the entire Gdf5-expressing population was genetically marked (arrows indicate tdTomato-positive, Gdf5-negative cells).
(C) Quantification of the percentage of Gdf5, tdTomato double-positive cells from all Gdf5-positive cells.
(D) Quantification of the percentage of tdTomato-positive, Gdf5-negative cells from all tdTomato-positive cells.
(E) Analysis ofGdf5 (green) and tdTomato (red) expression on E13.5–E15.5, following tamoxifen administration on E11.5, shows dynamic expression patterns and
the existence of newly recruited cells that express only Gdf5 (arrows).
(F) Analysis of Gdf5 and tdTomato gene expression in E15.5 knee joints following a single tamoxifen administration on E10.5–E13.5 shows that recruitment is a
continuous process (newly recruited cells are indicated by arrows).
(G) Analysis of tdTomato (red) and COL2A1 (white) protein localization on an E15.5 knee joint following a single tamoxifen administration on E11.5–E13.5. Bottom:
magnifications of the boxed areas at the top. Curved lines demarcate the epiphyseal domains where contribution of tdTomato-positive cells is seen.
Scale bars represent 50 mm (A) and 100 mm (B–G).Finally, our finding that cells were constantly leaving the Gdf5
expression domain suggested that the contribution of the Gdf5
lineage to the developing epiphyses is more intricate and fine-
tuned than has been appreciated previously (Koyama et al.,2580 Cell Reports 15, 2577–2587, June 21, 20162007; Rountree et al., 2004; Storm and Kingsley, 1999). To better
understand the temporal contribution of the Gdf5 lineage to the
epiphysis, we performed pulse-chase experiments using Gdf5-
CreER mice crossed with Rosa26-tdTomato mice. Following
Figure 3. Differential Contribution of Cell Subpopulations to Various Joint Tissues
Pulse-chase experiments using Gdf5-CreER, Rosa26-tdTomato mice were performed.
(A, C, D, and F) Tamoxifen was administered at various stages between E10.5 and E16.5. Examination on E18.5 shows the contribution of different Gdf5-ex-
pressing pools to the developing knee (A and C), elbow (D), and metacarpophalangeal (F) joints.
(B and E) Quantification of the percentage of tdTomato-positive cells contributing to articular cartilage from all labeled cells at the distal femur (B) and distal
humerus (E).
(G and H) Analysis ofGdf5 (green) and tdTomato (red) expression in E15.5 medial knee sections through the meniscus (top) andmid-sagittal sections through the
cruciate ligaments (bottom) following pulsing on E11.5 (G) and E12.5 (H) shows a substantial overlap in expression domains in the ligaments compared with the
meniscus (dashed lines demarcate the femur epiphysis).
Scale bars represent 100 mm.administration of a single dose of tamoxifen on E11.5–E13.5,
E15.5 embryos were stained for both tdTomato and collagen
type II a 1 (COL2A1). Activation on E11.5 resulted in a substantial
population of tdTomato, COL2A1 double-positive cells. Later
marking of Gdf5-expressing populations by tamoxifen adminis-
tration on E12.5–E13.5 (Figure 2G) resulted in a gradual decrease
in labeling of epiphyseal chondrocytes and labeled chondro-
cytes more proximal to the joint, indicating a spatial shift toward
the joint area. These results indicate that the cells lost their Gdf5
expression (Figure 2F), joined the growing cartilage, and differ-
entiated into chondrocytes (Figure 2G).
This set of experiments shows that the Gdf5 expression
domain is highly dynamic, with a constant influx of new cells
into the joint area as well as out of it into the epiphyses.
The Influx of Cells into the Joint Facilitates Lineage
Divergence
A possible implication of the influx model is that Gdf5-positive
cells recruited at different time points may give rise to specific
joint tissues. To address this hypothesis, we analyzed the spatio-
temporal contribution of cell lineages marked at different stagesto various joints of E18.5 embryos. For that, we administered
single doses of tamoxifen between E10.5 and E16.5 to embryos
heterozygous for Gdf5-CreER and Rosa26-tdTomato. As seen
in Figure 3, descendants of Gdf5-positive cells marked at
different time points populated different regions of the devel-
oping joints.
In the knee, Gdf5-positive cells were detected in the epiphy-
ses, articular cartilage, meniscus, and intra-articular liga-
ments. Early tamoxifen administration (on E10.5) resulted in
tdTomato-positive cells located mostly at the epiphyses. How-
ever, when tamoxifen was administered at E11.5, tdTomato-
positive cells were also observed in the articular cartilage.
Upon activation on E12.5–E13.5, the number of tdTomato-pos-
itive cells in the epiphyses decreased, whereas their relative
number in the articular cartilage increased. Finally, following
activation on E14.5–E15.5, the expression was restricted to
the most superficial layer of the articular cartilage (Figures 3A
and 3B). Tamoxifen administration at all stages led to a contri-
bution of tdTomato-positive cells to the meniscus and intra-
articular ligaments. However, whereas pulsing at early and
intermediate stages led to a massive contribution throughoutCell Reports 15, 2577–2587, June 21, 2016 2581
the tissues, at later stages it resulted in an exclusive contribu-
tion of these cells to the edges of the meniscus (Figure 3A)
and intra-articular ligament (Figure 3C).
In the elbow joint, a similar trend was observed, except that a
contribution of Gdf5-positive cells to the articular cartilage was
observed following activation on E12.5 (Figures 3D and 3E).
The metacarpophalangeal joint also exhibited a similar spatio-
temporal pattern. However, administration on E13.5 (Figure 3F)
resulted in prominent labeling of the joint capsule. Finally, the
different contribution of labeled cells to epiphyseal chondrocytes
seen in knee sections (Figures 3A and 3C) prompted us to further
examine the spatial distribution ofGdf5- and tdTomato-express-
ing cells in E15.5 embryos pulsed on E11.5 (Figure 3G) or E12.5
(Figure 3H). Mid-sagittal sections through the knee, where the
cruciate ligaments were visualized, revealed significantly more
cells that expressed both genes (Figures 3G and 3H, bottom)
and a clear reduction in tdTomato-positive, Gdf5-negative cells
compared with medial sections showing the menisci. Presum-
ably, the latter cell population highly contributes to the epiphysis
(Figures 3G and 3H, top).
Importantly, in all joints we observed asymmetry in the contri-
bution of Gdf5-positive cells to the skeletal elements at the two
sides of the joint. For example, the femur and the humerus
were more extensively marked than the opposing bones. This
observation suggests that asymmetric contribution may be
part of the morphogenetic process (Figure 1C).
Overall, the spatiotemporal differences in Gdf5 expression
patterns show the dynamics of the establishment of the different
joint tissues. Although some elements, like the cruciate liga-
ments and menisci, are formed by constant recruitment of new
Gdf5-expressing cells that maintain its expression, others, like
the metacarpophalangeal joint capsule, originate from a tempo-
rally specific group of cells. It is tempting to speculate that this
mode of development may facilitate lineage divergence into
different cell fates to allow the formation of the various tissues
that compose the joint.
A Continuous Influx of Sox9-Positive Cells May
Contribute to Joint Morphogenesis
Previously, it was shown that joint cells originate from Sox9-pos-
itive chondroprogenitor cells (Soeda et al., 2010). To confirm this,
we crossed Sox9-CreER mice with the Rosa26-tdTomato re-
porter. Examination of E15.5 knee and elbow joints following
administration of a single tamoxifen dose at E10.5 showed that
all structures of the joints were tdTomato-positive, thus origi-
nating from an early population of Sox9-positive cells (Figures
S3Aa–S3Ad). To further establish that Gdf5-positive cells are
derived from that early pool, double ISH for tdTomato and
Gdf5 was performed on sections through the knee of Sox9-
CreER, Rosa26-tdTomato heterozygous embryos. The co-
expression of both markers confirmed that conclusion
(Figure S3Ae).
Several studies have suggested that cells from the vicinity
may migrate into the developing joint (Hyde et al., 2008;
Koyama et al., 2007; Pacifici et al., 2006; Ray et al., 2015).
To locate the source that may supply new cells to the devel-
oping joint, we next analyzed the expression of the two
abovementioned genes alongside COL2A1, a marker of differ-2582 Cell Reports 15, 2577–2587, June 21, 2016entiating chondrocytes, throughout joint development. To
visualize all three markers simultaneously, double ISH for
Sox9 and Gdf5 was performed together with immunofluores-
cence staining for COL2A1. Examination of the elbow and
knee joints at E12 revealed, as expected, a population of
Sox9-Gdf5 double-positive cells at the presumptive joint
area. This population was later observed at all examined
stages (Figures 4A–4F and S3Ca–S3Cf). However, around
the developing joint, we observed a cloud of Sox9-positive
cells that did not express Col2a1 or Gdf5 (Figures 4A and
S3Ca). That population was also prominent in double immu-
nofluorescence staining for SOX9 and COL2A1 (Figure S3B).
As development proceeded, two concurrent events were
observed: massive growth and morphogenesis of the joint and
a gradual reduction in the population of Sox9-positive, Col2a1,
Gdf5-negative cells around the joint (Figures 4A–4F and S3Ca–
S3Cf; arrows), which was also confirmed by immunofluorescent
staining (Figure S3B). Interestingly, in the interzone, between the
Col2a1-positive cells that flanked it and the Gdf5 expression
domain, another population of cells that was Sox9-positive
and Col2a1, Gdf5-negative was observed (Figures 4C, 4D, and
S3C; dashed arrows). These cells were likely descendants of
early Gdf5-positive cells that had lost Gdf5 expression, as we
demonstrated previously (Figure 2), and were in the process of
differentiation to chondrocytes while integrating into the epiphy-
ses (Figure S3D).
Together, these results suggest that Sox9-positive, Col2a1,
Gdf5-negative cells from the vicinity of the joint migrate into
the forming joint, turn onGdf5 expression, and contribute to joint
development.
DISCUSSION
Over the years, a general scheme of organogenesis has been
widely adopted. This scheme has guided efforts to trace the lin-
eages of organ-forming cells to identify their progenitors. In
accordance with this view, Gdf5-positive interzone cells have
been suggested as joint progenitors. However, the data we pre-
sent here are inconsistent with the progenitor model sensu
stricto and favor an alternative strategy for joint development
that involves a constant influx of new cells that are integrated
into the forming organ to sustain its development.
Several lines of evidence in our study are inconsistent with
the view that joint progenitor cells are all specified at an early
stage of limb development. None of our attempts, using a
knockin Gdf5-CreER line, to capture the entire progenitor
population by a single Cre activation succeeded; each time,
only a certain subpopulation of joint cells was marked. Only
several doses of tamoxifen at different developmental stages
resulted in extensive labeling throughout the joint. Moreover,
cell proliferation assays revealed a reduction in the prolifera-
tion of the Gdf5 lineage through development that could not
accommodate the demands of the developing joint. Finally,
our finding of a time-dependent increase in the number of
new Gdf5-positive cells in the interzone may also be incom-
patible with the progenitor model.
A possible limitation of our approachwould be low recombina-
tion activity of the newGdf5-CreER line, which would lead to low
Figure 4. Gene Expression Dynamics Suggests that Influx of Sox9-Positive Cells Contributes to Joint Formation
(A–F) Gdf5 and Sox9 double ISH and COL2A1 immunofluorescent staining on sections through E12–E15.5 knee joints. Arrows indicate a population of Sox9-
positive Gdf5, COL2A1-negative cells outside (solid arrows) and inside (dashed arrows) of the interzone. Scale bars represent 100 mm.labeling efficacy. However, comparable levels of tdTomato and
endogenous Gdf5 expression observed and computed shortly
after Cre activation suggest that our new line acts efficiently on
the Rosa26-tdTomato reporter line.
The concept of the addition of cells to a developing organ
instead of relying exclusively on proliferation of progenitor cells
is interesting. Previously, we showed that cells that form bone
eminences and the patella are added secondarily to the alreadyestablished bone shaft anlage (Blitz et al., 2009, 2013; Eyal et al.,
2015). Although these studies fall short of providing direct
evidence for the continuity of this process, the different timing
suggests that the influx model may be a broader phenomenon
in skeletal development.
Intriguingly, our findings may appear to disagree with Holder’s
seminal experiment in which removal of the interzone led to
failure in joint development (Holder, 1977). There are severalCell Reports 15, 2577–2587, June 21, 2016 2583
Figure 5. A Revised Model for Joint Devel-
opment
Joint development involves constant specification
of new Gdf5-positive cells from Sox9-expressing
chondroprogenitors.
(A) These cells exhibit a highly dynamic behavior.
Thus, some early-specified cells (yellow) will
quickly lose Gdf5 expression and contribute to the
growing epiphyses more than later-recruited cells
(orange and red).
(B) In contrast, the constant influx of specified cells
that are destined to contribute to the intra-articular
ligaments will maintain Gdf5 expression and their
localization to the developing joint site.possible ways for reconciling these seemingly opposing conclu-
sions. For example, Holder might have removed with the inter-
zone the surrounding tissues, including the potential source for
migrating Gdf5-positive cells, leading to failure in joint develop-
ment. Also, several lines of evidence support the notion that
the interzone is a vital signaling center in joint development
(Decker et al., 2014; Longobardi et al., 2015). Thus, removal of
the interzone could have eliminated the regulatory signals medi-
ating the recruitment process. A third possibility is that Holder
also removed muscles, which were shown previously by us
and others to be essential for joint development (Kahn et al.,
2009; Nowlan et al., 2010; Pitsillides and Ashhurst, 2008;
Shwartz et al., 2013).
A central question in organ development is the mechanism
by which lineage divergence occurs to form different tissues.
This question is particularly interesting in the case of joint
development because all joint tissues were shown to originate
from Gdf5-expressing cells (Koyama et al., 2007, 2008; Roun-
tree et al., 2004). Previous studies have suggested two
possible mechanisms for the divergence into epiphyseal and
articular chondrocytes based on either temporal or spatial
differences. The temporal hypothesis is that cells that express
Gdf5 early will contribute to the epiphysis (Storm and Kings-
ley, 1999), whereas the spatial hypothesis is that the location
of the progenitors in the interzone determines the ultimate
lineage destination (Ito and Kida, 2000). We propose the2584 Cell Reports 15, 2577–2587, June 21, 2016high cellular dynamics of Gdf5 expres-
sion as the underlying factor of tissue
divergence.
Although the mechanism that trans-
lates Gdf5 expression dynamics to line-
age divergence is yet to be deciphered,
we identify two important parameters,
the duration and time of onset of Gdf5
expression, whose combination may
determine lineage divergence (Figure 5).
For example, cells that would eventually
contribute to the epiphysis lost Gdf5
expression, whereas cells that contrib-
uted to the meniscus and knee cruciate
ligaments exhibited completely different
dynamics and maintained Gdf5 expres-
sion. Interestingly, articular cartilage wasalso found to express Gdf5 continually. However, the recruit-
ment of most of these cells started 1 day later than in the liga-
ments and menisci. This differential behavior can serve as a
mechanism by which cells contributing to different joint tissues
acquire their fate (Figure 5). This notion is supported by previous
studies showing that Gdf5 is essential for the development of
intra-articular ligaments (Harada et al., 2007), which were absent
in bp mice, and that human mesenchymal stem cells (hMSCs)
and murine adipose tissue-derived mesenchymal stem cells
treated with GDF5 showed an elevation in tendon-specific
markers such as scleraxis (Scx) (Park et al., 2010; Tan et al.,
2012). An example for the onset of Gdf5 expression as a cue
for lineage divergence is the case of the metacarpophalangeal
joint capsule, where the contributing cells start to express this
gene only on E13.5.
The influx of new cells and the dynamic behavior of joint-form-
ing, Gdf5-expressing cells may provide flexibility both in devel-
opment and during evolution. Various joint structures support
specific functions and mechanical needs. Development through
multiple steps, some of which are lineage-specific, may enable
faster and more efficient changes in joint structure by manipu-
lating only a subpopulation of joint-forming cells.
A key question that remains to be solved is the source of the re-
cruited cells. Previous studies have shown that all joint structures
originate from matrilin 1-negative (Hyde et al., 2007) and Sox9-
positive cells (Soeda et al., 2010). Other works indicate that cells
are recruited into the developing joint (Hyde et al., 2008; Koyama
et al., 2007; Pacifici et al., 2006; Ray et al., 2015). Our study iden-
tifies a population of Sox9-positive, Col2a1, Gdf5-negative cells
outsideof the joint area thatmayserveasanexternal source.How-
ever, this supposition is yet to be conclusively confirmed. Another
possibility is an internal origin correlating to the Sox9-positive,
Col2a1, Gdf5-negative cells we observed in the interzone. How-
ever, we believe that there are several indications for recruitment
from an outside source.
First, the Gdf5 expression domain is initially very broad, occu-
pying the entire interzone and leaving no room for Sox9+,Gdf5,
Col2a1 cells to contribute to the Gdf5-expressing population.
Moreover, as we demonstrate, the CreERT2 system is highly
efficient and is thus likely to mark the majority of Gdf5-positive
interzone cells. Nonetheless, we cannot rule out the possibility
that a unique subpopulation of unlabeled Gdf5-positive inter-
zone cells contributes to joint growth and, as an internal source,
to cell recruitment. Last, we demonstrate a clear decrease in the
number of Sox9+, Gdf5 cells flanking the forming joint during
development, supporting the argument that this population is
the source for joint cells.
Interestingly, a recent study by Ray et al. (2015) suggests that
articular cartilage originates from proliferating chondrocytes,
proposing another possible source outside of the interzone.
However, because a different system was used in that study,
the Col2a1-CreERT2 mouse, the exact spatial and temporal rela-
tionships between the process identified by Ray et al. (2015) and
the one described here are yet to be determined. A plausible
explanation for the apparent differences is that both these pro-
cesses contribute to joint formation in varying proportions.
Thus, examination of different joints at different time points
may yield inconsistent results.
From a medical perspective, joints exhibit a very limited ca-
pacity for regeneration (Iwamoto et al., 2013; Sandell, 2012).
Our results suggest that, to improve regeneration, it may be
necessary to search for a mechanism that can enhance or acti-
vate cell recruitment.
In conclusion, our findings indicate that joints do not form from
a single pool of early-specified Gdf5-positive cells but, rather,
through a continuous influx of Gdf5-positive cells, hence the
term influx model. Moreover, we show highly dynamic spatio-
temporal patterns of Gdf5 expression by interzone cells, which
may serve as differentiation cues. An additional differentiation
signal may be the temporal specification of cells that will
contribute differentially to the various tissues of the mature joint,
thus facilitating lineage divergence of Gdf5-positive cells.EXPERIMENTAL PROCEDURES
Animals
All experiments involving mice were approved by the Institutional Animal Care
and Use Committee (IACUC) of the Weizmann Institute. Rosa26-tdTomato
mice (B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J) have been
described previously (Madisen et al., 2010; Soeda et al., 2010). The generation
of Gdf5-CreER knockin mice is described in the Supplemental Experimental
Procedures. To create Gdf5-CreER, Rosa26-tdTomato mice, floxed Rosa26-
tdTomato mice were mated with Gdf5-CreER mice.
For harvesting of embryos, timed pregnant females were sacrificed by cer-
vical dislocation.Tamoxifen Administration
Pregnant female mice were administered 0.12–0.18 mg/g tamoxifen/body
weight in corn oil by oral gavage.
Cryosectioning
Embryos were fixed in 4% paraformaldehyde (PFA)/PBS for 3 hr at 4C,
washed overnight in 30% sucrose/PBS at 4C, embedded in O.C.T., and
sectioned at a thickness of 10 mm.
Immunofluorescent Staining
For paraffin section immunofluorescence, embryos were fixed overnight in 4%
PFA/PBS, dehydrated to 100% ethanol, embedded in paraffin, and sectioned
at a thickness of 7 mm. 10 mM sodium citrate (pH 6.0) was used for antigen
retrieval. Slides were incubated overnight at 4C with primary antibody anti-
BrdU (AbD) diluted 1:200 and with biotinylated anti-RFP (Abcam) diluted
1:100 in blocking solution to visualize tdTomato. For COL2A1 and tdTomato
double immunostaining, after staining for tdTomato, slides were subjected
to additional digestion by Proteinase K (Sigma). Slides were incubated over-
night at 4C with the primary antibody anti-COL2 (Developmental Studies
Hybridoma Bank [DSHB], University of Iowa) 1:50 in blocking solution.
Following fluorescence ISH, slides were incubated overnight at 4Cwith the
primary antibody anti-COL2 (DSHB) 1:50 in blocking solution or with anti-RFP
(Abcam) diluted 1:100 in blocking solution to visualize tdTomato.
In Situ Hybridization
Non-fluorescent ISH on paraffin sections was performed using a digoxigenin
(DIG)-labeled probe for Gdf5. Double fluorescence ISH on paraffin sections
was performed using fluorescein- and DIG-labeled probes. The extended pro-
tocol was described by Shwartz and Zelzer (2014).
BrdU Administration
Mice were injected intraperitoneally with 100 mg/kg of body weight BrdU
labeling reagent (Sigma) and sacrificed 4 hr later. Forelimbs and hindlimbs
were fixed in 4% PFA overnight at 4C, dehydrated in ethanol, and embedded
in paraffin.
Cell Count
For calculation of the percentage of tdTomato-positive cells contributing to the
articular cartilage, 10-mm thick cryosections were counterstained with DAPI.
tdTomato-positive cells were manually counted at the distal femoral and hu-
meral heads as well as at the articular cartilage area, identified histologically
as the external four to five cell layers. The percentage was calculated for
each photographed section and averaged first for each embryo and then for
each analyzed stage of tamoxifen administration.
To test the proliferation of tdTomato-positive cells, tdTomato-positive and
tdTomato-BrdU-double positive cells were counted manually in BrdU-, RFP-,
and DAPI-stained paraffin sections. In both experiments, 3-12 sections of
each joint from each embryo were used, and three embryos from different lit-
ters were analyzed for each embryonic stage. Sections were photographed
and examined by an LSM 710 or 780 confocal microscope. Data are repre-
sented as mean ± SD.
Co-localization Measurements
Section double ISH for tdTomato and Gdf5 was imaged with an LSM 710 or
780 confocal microscope. The co-localization analysis was performed using
the Imaris 8.2 colocalization module. For each analyzed picture, a region of in-
terest covering the entire area of the knee joint containing tdTomato- and
Gdf5-positive cells was defined and used for all measurements. Two to eleven
sections of each joint from each embryo were used, and two to three embryos
from two to three different litters were analyzed for each embryonic stage. The
results represent all measured values ± SD.
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